ENDRA Life Sciences NDRA 深 滬
已收盤 07-31 16:00:00 美东时间
4.70
+0.370
+8.55%
華盛通- 最 高4.70
- 今 開4.41
- 成交量 1.87万股
- 最 低 4.25
- 昨 收 4.33
- 總市值 596.94万
- 52周最高 9.85
- 市盈率 靜 --
- 換手率 1.47%
- 52周最低 2.96
- 委 比 7.41%
- 總股本 127.01万
- 歷史最高 205800.00
- 量 比 1.50
- 振 幅 10.39%
- 歷史最低 2.90
- 每 手 1
- 風險率 0.83%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多ASP Isotopes Announces Proposed Merger of Noble Africa with ENDRA Life Sciences and Approximately $50 Million Concurrent Private Placement Financing
<p>Noble Africa LLC, a subsidiary of ASP Isotopes Inc., will merge with a subsidiary of ENDRA Life Sciences Inc. in a transaction expected to create Noble Africa Inc., a Nasdaq-listed company focused on Renergen’s Virginia Gas helium project. The merger, along with a concurrent private placement targeting $50 million in gross proceeds, aims to provide capital and market access for project development. ASP Isotopes will own approximately 89% of th...
06-25 13:30
美股大行评级 | 瑞杰金融上调美光目标价从530美元升至1100美元；AMD、Arm、戴尔、英特尔等获多家机构上调目标价
今日重点评级关注：Ascendiant Capital：维持RenovoRx"买入"评级，目标价从13.5美元升至14美元；BTIG：维持Jade Biosciences"买入"评级，目标价从39美元升至74美元
06-02 16:25
Dell Technologies To Gain Nearly 79%? Here Are 10 Analyst Calls Investors Should Know
Wall Street analysts updated views on notable stocks. See changes on analyst ratings page. Price targets raised/cut, ratings maintained/changed.
06-01 20:43
ENDRA Life Sciences Q1 EPS $(1.09) Beats $(1.14) Estimate
ENDRA Life Sciences (NASDAQ:NDRA) reported quarterly losses of $(1.09) per share which beat the analyst consensus estimate of $(1.14) by 4.39 percent. This is a 41.4 percent increase over losses of $(1.86) per share from
05-18 20:04
ENDRA Life Sciences Reports Multi-Site Validation And MRI-Level Accuracy Of TAEUS Liver Device
The analysis combined data from 64 patients in the U.S. and Canada, including an external validation site in London, Ontario, across independent operators and patient populations. TAEUS Liver's thermoacoustic fat
05-14 20:09
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Gainers Immutep (NASDAQ:IMMP) shares rose 135.4% to $0.74 during Wednesday's p...
04-15 20:05
ENDRA Life Sciences Q4 EPS $(3.25) Misses $(1.95) Estimate
ENDRA Life Sciences (NASDAQ:NDRA) reported quarterly losses of $(3.25) per share which missed the analyst consensus estimate of $(1.95) by 66.67 percent. This is a 55.78 percent increase over losses of $(7.35) per share
04-01 05:22
